Navigation Links
CoolTouch® Issued New “Endovenous Laser Treatment” Patent
Date:5/9/2013

Roseville, CA (PRWEB) May 09, 2013

CoolTouch Inc., a medical device manufacturer, proudly announces the issuance of USPTO patent # 8,409,183 titled “Endovenous Laser Treatment Generating Reduced Blood Coagulation.” This patent covers the method of using the special properties of micro-pulsed lasers to treat varicose veins while reducing the production of thrombus (clotted blood that can cause serious complications.) During the past 8 years and over 20,000 varicose vein treatments, CoolTouch physicians using the CTEV micro-pulsed laser along with the Clear Tip™ protocol, have reported 50% fewer thromboembolic complications when compared to other heat ablation methods.

Co-Inventor Mitchel P. Goldman, MD of San Diego, CA. "I have helped develop many different endovenous ablation technologies, but I've used the 1320 nanometer CTEV laser for almost 10 years and nothing else works better with fewer complications.”

Two recently published peer-reviewed papers; “Thrombus Formation using Endovenous Lasers: an In Vitro Experiment” in the journal of Phlebology and “Endoluminal Laser Delivery Mode and Wavelength Effects on Varicose Veins in an Ex Vivo Model” in Lasers in Surgery and Medicine describe the mechanism of the ‘183 patent. In both studies several different lasers and fiber optic catheters were compared for their ability to coagulate blood and avoid perforations in the vein. Micro-pulsed lasers like the CoolTouch CTEV showed significantly less thrombus formation and fewer perforations compared to other lasers.

David Hennings CEO of CoolTouch states "It is our aim to provide products that have superior performance and great value to the user. The CoolTouch CTEV laser with Clear Tip technology not only provides the best patient outcomes but also reduces potential costly and debilitating complications that could lead to readmission or follow-up treatment. With a variety of cost-effective single and multiple-use fiber optic choices, the CoolTouch CTEV laser system is ideal for the new healthcare environment of best care at lower cost.”

CoolTouch Inc. is a leading designer and manufacturer of innovative, advanced laser products for medical professionals. CoolTouch pioneered the use of mid-infrared lasers like the 1320 nm CTEV and owns patents (7,524,316; 7,921,854) that cover the use of 1319, 1320 and 1470 nanometer wavelengths for the treatment of varicose veins and the use of radial and protected tip fiber optics. CoolTouch products are manufactured in Roseville, CA.

Read the full story at http://www.prweb.com/releases/2013/5/prweb10711239.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Patent Issued for Apparel and Textile Fabric with Antimicrobial Properties
2. New Guidelines Issued for Genetic Screening in Newborns, Children
3. First-Ever Guidelines Issued for Treating Type 2 Diabetes in Kids
4. DePuy Pinnacle Lawsuits: Explant Preservation Order Issued in Federal DePuy Pinnacle Hip Litigation
5. Method patent issued for investigational new class of pain medication
6. Trustifi Patent 8,341,023 Granted by USPTO and New Patent to be Issued for Postmarked Email
7. Guidelines Issued to Resolve Temporary Facial Paralysis
8. Guidelines Issued for New Blood Thinner Brilinta
9. New Guidelines Issued for Biopsy Use in Melanoma Patients
10. Guidelines Issued for When Docs Should Order Vascular Testing
11. New Guidelines Issued for Severe Lupus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... 2016 , ... The temporary closing of Bruton Memorial Library on June 21 due to a ... new, often overlooked aspect of head lice: the parasite’s ability to live away from a ... occurrence, but a necessary one in the event that lice have simply gotten out of ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van ... Wellness at Work award to iHire in recognition of their exemplary accomplishments in worksite ... 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum ...
(Date:6/24/2016)... ... ... was in a crisis. Her son James, eight, was out of control. Prone to extreme ... “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If there was ... other children and say he was going to kill them. If we were driving ...
(Date:6/24/2016)... Rhinebeck, NY (PRWEB) , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of ... of companies that call for a minimum wage raise to $12 an hour by 2020 ... wage. This will restore the lost value of the minimum wage, assure the wage floor ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... actively feeding the Frederick area economy by obtaining investment capital for emerging technology ... past 2½ years that have already resulted in more than a million dollars ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ., ... developing innovative inhaled drugs, announced today that it was ... Investments reconstituted its comprehensive set of U.S. and ... "This is an important milestone for Pulmatrix," said Chief ... shareholder awareness of our progress in developing drugs for ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... - Forecast to 2022" report to their offering. ... for the patients with kidney failure, it replaces the function ... the patient,s blood and thus the treatment helps to keep ... in balance. Increasing number of ESRD patients ...
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
Breaking Medicine Technology: